We are live on ! Find out more
IFA

Invus Financial Advisors Portfolio holdings

AUM $89.2M
1-Year Est. Return 10.79%
This Fund
S&P 500
This Quarter Est. Return
+11.92%
1 Year Est. Return
-10.79%
3 Year Est. Return
-29.46%
5 Year Est. Return
10 Year Est. Return
AUM
$197M
AUM Growth
Cap. Flow
+$179M
Cap. Flow %
90.65%
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 69.67%
2 Technology 30.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OYST
1
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$63.3M 32.1%
+2,590,015
New +$45.5M
YEXT icon
2
Yext
YEXT
$694M
$59.8M 30.33%
+4,146,784
New +$64.3M
NVCR icon
3
NovoCure
NVCR
$2.06B
$39.7M 20.13%
+470,884
New +$38M
RCUS icon
4
Arcus Biosciences
RCUS
$3.72B
$18.6M 9.44%
+1,842,077
New +$15.5M
UBX
5
DELISTED
Unity Biotechnology
UBX
$15.8M 8.01%
+219,000
New +$15.5M

Similar funds

Invus Financial Advisors's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Invus Financial Advisors, which disclosed 5 positions worth $197M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Yext: 4,146,784 shares worth $59.8M.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, followed by Technology.

  • Invus Financial Advisors's largest Q4 2019 buy was Yext: 4,146,784 shares worth $59.8M.
  • Invus Financial Advisors's ten largest holdings make up 100% of its $197M portfolio in Q4 2019.
  • Invus Financial Advisors disclosed 5 positions in Q4 2019, its first 13F filing on record.

Based on Invus Financial Advisors's 13F filing for Q4 2019, filed 13 Feb 2020.